Published in Cancer Res on December 01, 1996
Glycosylation defining cancer malignancy: new wine in an old bottle. Proc Natl Acad Sci U S A (2002) 3.73
Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis. Proc Natl Acad Sci U S A (2002) 3.10
Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc Natl Acad Sci U S A (2001) 3.04
P-selectin deficiency attenuates tumor growth and metastasis. Proc Natl Acad Sci U S A (1998) 3.02
Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family. Glycobiology (2011) 2.56
B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells. Blood (2008) 2.41
Vascular niche E-selectin regulates hematopoietic stem cell dormancy, self renewal and chemoresistance. Nat Med (2012) 2.33
Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma. Blood (2007) 2.31
Alterations in the serum glycome due to metastatic prostate cancer. J Proteome Res (2007) 2.30
Perspectives on the significance of altered glycosylation of glycoproteins in cancer. Glycoconj J (1997) 2.21
The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. J Transl Med (2005) 1.95
The WNKs: atypical protein kinases with pleiotropic actions. Physiol Rev (2011) 1.88
CD147 immunoglobulin superfamily receptor function and role in pathology. Exp Mol Pathol (2007) 1.77
Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis. J Clin Invest (1998) 1.73
Sialyl Lewis(x)-mediated, PSGL-1-independent rolling adhesion on P-selectin. Biophys J (2000) 1.65
Evidence for a human-specific mechanism for diet and antibody-mediated inflammation in carcinoma progression. Proc Natl Acad Sci U S A (2008) 1.62
Core 2 N-acetylglucosaminyltransferase-1 expression induces aggressive potential of testicular germ cell tumor. Int J Cancer (2010) 1.58
Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis. J Clin Invest (2012) 1.53
Chemical glycosylation in the synthesis of glycoconjugate antitumour vaccines. Nature (2007) 1.51
Hypoxia induces adhesion molecules on cancer cells: A missing link between Warburg effect and induction of selectin-ligand carbohydrates. Proc Natl Acad Sci U S A (2004) 1.50
Specific glycosphingolipids mediate epithelial-to-mesenchymal transition of human and mouse epithelial cell lines. Proc Natl Acad Sci U S A (2009) 1.49
Fatty acid 2-Hydroxylation in mammalian sphingolipid biology. Biochim Biophys Acta (2009) 1.45
Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression. Proc Natl Acad Sci U S A (2002) 1.44
Sialylation of beta1 integrins blocks cell adhesion to galectin-3 and protects cells against galectin-3-induced apoptosis. J Biol Chem (2008) 1.40
Bacteria and cancer: cause, coincidence or cure? A review. J Transl Med (2006) 1.38
Monolayer coated gold nanoparticles for delivery applications. Adv Drug Deliv Rev (2011) 1.36
Sialidase and malignancy: a minireview. Glycoconj J (2004) 1.32
The glycosphingolipid globotriaosylceramide in the metastatic transformation of colon cancer. Proc Natl Acad Sci U S A (2005) 1.32
Signaling defects in anti-tumor T cells. Immunol Rev (2008) 1.28
A glycobiology review: carbohydrates, lectins and implications in cancer therapeutics. Acta Histochem (2010) 1.27
Combining results from lectin affinity chromatography and glycocapture approaches substantially improves the coverage of the glycoproteome. Mol Cell Proteomics (2008) 1.26
Regulation of integrin functions by N-glycans. Glycoconj J (2004) 1.25
Quantitative serum glycomics of esophageal adenocarcinoma and other esophageal disease onsets. J Proteome Res (2009) 1.25
Inhibition of glycolipid shedding rescues recognition of a CD1+ T cell lymphoma by natural killer T (NKT) cells. Proc Natl Acad Sci U S A (2002) 1.25
Glycosylation defining cancer cell motility and invasiveness. Glycoconj J (2004) 1.24
Phage-display library selection of high-affinity human single-chain antibodies to tumor-associated carbohydrate antigens sialyl Lewisx and Lewisx. Proc Natl Acad Sci U S A (1999) 1.24
The human LARGE gene from 22q12.3-q13.1 is a new, distinct member of the glycosyltransferase gene family. Proc Natl Acad Sci U S A (1999) 1.23
Molecular mechanism for cancer-associated induction of sialyl Lewis X and sialyl Lewis A expression-The Warburg effect revisited. Glycoconj J (2004) 1.23
Complement inhibition in cancer therapy. Semin Immunol (2013) 1.20
Identifying cancer biomarkers by mass spectrometry-based glycomics. Electrophoresis (2012) 1.19
Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance. J Clin Invest (2014) 1.16
Traveling for the glycosphingolipid path. Glycoconj J (2001) 1.16
The role of immunoglobulin superfamily cell adhesion molecules in cancer metastasis. Int J Cell Biol (2012) 1.15
N-linked glycosylation of the liver cancer biomarker GP73. J Cell Biochem (2008) 1.14
Synthesis of reference standards to enable single cell metabolomic studies of tetramethylrhodamine-labeled ganglioside GM1. Carbohydr Res (2006) 1.11
Specific glycosylation of membrane proteins in epithelial ovarian cancer cell lines: glycan structures reflect gene expression and DNA methylation status. Mol Cell Proteomics (2014) 1.11
Chondroitin sulfates play a major role in breast cancer metastasis: a role for CSPG4 and CHST11 gene expression in forming surface P-selectin ligands in aggressive breast cancer cells. Breast Cancer Res (2011) 1.11
The development of an integrated platform to identify breast cancer glycoproteome changes in human serum. J Chromatogr A (2009) 1.06
Molecular Microscopy of Brain Gangliosides: Illustrating their Distribution in Hippocampal Cell Layers. ACS Chem Neurosci (2011) 1.05
Shiga toxin and its use in targeted cancer therapy and imaging. Microb Biotechnol (2011) 1.05
Cancer invasion and metastasis: interacting ecosystems. Virchows Arch (2009) 1.05
Are selectins involved in metastasis? Clin Exp Metastasis (1999) 1.04
Potential roles of N-glycosylation in cell adhesion. Glycoconj J (2012) 1.04
Involvement of O-glycosylation defining oncofetal fibronectin in epithelial-mesenchymal transition process. Proc Natl Acad Sci U S A (2011) 1.03
Altered melanoma cell surface glycosylation mediates organ specific adhesion and metastasis via lectin receptors on the lung vascular endothelium. Clin Exp Metastasis (2005) 1.03
Signaling Transduction Network Mediated by Tumor Suppressor/Susceptibility Genes in NPC. Curr Genomics (2009) 1.03
Targeted glycoproteomic identification of cancer cell glycosylation. Glycobiology (2009) 1.02
Sphingolipids and expression regulation of genes in cancer. Prog Lipid Res (2010) 1.02
Renal cell carcinoma-derived gangliosides suppress nuclear factor-kappaB activation in T cells. J Clin Invest (1999) 1.02
Reversion of the Jun-induced oncogenic phenotype by enhanced synthesis of sialosyllactosylceramide (GM3 ganglioside). Proc Natl Acad Sci U S A (2004) 1.01
Synthetic carbohydrate-based anticancer vaccines: the Memorial Sloan-Kettering experience. Expert Rev Vaccines (2009) 1.01
Golgi apparatus immunolocalization of endomannosidase suggests post-endoplasmic reticulum glucose trimming: implications for quality control. Mol Biol Cell (2000) 1.00
Histone acetylation-mediated glycosyltransferase gene regulation in mouse brain during development. J Neurochem (2011) 1.00
Cellular interaction through LewisX cluster: theoretical studies. J Mol Model (2008) 0.99
Defining putative glycan cancer biomarkers by MS. Bioanalysis (2012) 0.99
Biological modulation by lectins and their ligands in tumor progression and metastasis. Anticancer Agents Med Chem (2008) 0.98
Recent Development in Carbohydrate Based Anti-cancer Vaccines. J Carbohydr Chem (2012) 0.98
Probing the substrate specificity of Golgi alpha-mannosidase II by use of synthetic oligosaccharides and a catalytic nucleophile mutant. J Am Chem Soc (2008) 0.97
Plasma-membrane-associated sialidase (NEU3) differentially regulates integrin-mediated cell proliferation through laminin- and fibronectin-derived signalling. Biochem J (2006) 0.96
Shiga toxin receptor Gb3Cer/CD77: tumor-association and promising therapeutic target in pancreas and colon cancer. PLoS One (2009) 0.96
What makes cancer stem cell markers different? Springerplus (2013) 0.96
N -butyldeoxynojirimycin reduces growth and ganglioside content of experimental mouse brain tumours. Br J Cancer (2001) 0.95
AsialoGM1 and integrin alpha2beta1 mediate prostate cancer progression. Int J Oncol (2009) 0.94
Sialidase significance for cancer progression. Glycoconj J (2012) 0.94
Ganglioside synthase knockout in oncogene-transformed fibroblasts depletes gangliosides and impairs tumor growth. Oncogene (2010) 0.92
Thematic review series: sphingolipids. Ganglioside GM3 suppresses the proangiogenic effects of vascular endothelial growth factor and ganglioside GD1a. J Lipid Res (2008) 0.92
In vivo tumor cell adhesion in the pulmonary microvasculature is exclusively mediated by tumor cell--endothelial cell interaction. BMC Cancer (2010) 0.92
An adenovirus vector incorporating carbohydrate binding domains utilizes glycans for gene transfer. PLoS One (2013) 0.91
Identification of global alteration of translational regulation in glioma in vivo. PLoS One (2012) 0.91
Understanding carbohydrate-carbohydrate interactions by means of glyconanotechnology. Glycoconj J (2004) 0.90
Ganglioside biochemistry. ISRN Biochem (2012) 0.89
The emerging importance of α-L-fucose in human breast cancer: a review. Am J Transl Res (2011) 0.89
N-glycan profiling by microchip electrophoresis to differentiate disease states related to esophageal adenocarcinoma. Anal Chem (2012) 0.89
Combination of tunicamycin with anticancer drugs synergistically enhances their toxicity in multidrug-resistant human ovarian cystadenocarcinoma cells. Cancer Cell Int (2007) 0.89
Glycobiology of neuroblastoma: impact on tumor behavior, prognosis, and therapeutic strategies. Front Oncol (2014) 0.88
Comparative profiling of N-glycans isolated from serum samples of ovarian cancer patients and analyzed by microchip electrophoresis. J Proteome Res (2013) 0.88
Analysis of cell surface carbohydrate expression patterns in normal and tumorigenic human breast cell lines using lectin arrays. Anal Chem (2007) 0.88
Sialylated Lewis x antigen bearing glycoproteins in human plasma. J Proteome Res (2010) 0.87
Comparative glycomic profiling of isotopically permethylated N-glycans by liquid chromatography/electrospray ionization mass spectrometry. Rapid Commun Mass Spectrom (2013) 0.87
C2-O-sLeX glycoproteins are E-selectin ligands that regulate invasion of human colon and hepatic carcinoma cells. PLoS One (2011) 0.87
Modulation of MUC1 mucin as an escape mechanism of breast cancer cells from autologous cytotoxic T-lymphocytes. Br J Cancer (2001) 0.87
Overexpression of α (1,6) fucosyltransferase associated with aggressive prostate cancer. Glycobiology (2014) 0.87
Alterations in neuroblastoma ganglioside synthesis by induction of GD1b synthase by retinoic acid. Br J Cancer (2004) 0.86
Localization and imaging of gangliosides in mouse brain tissue sections by laserspray ionization inlet. J Lipid Res (2012) 0.86
CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like Cells. PLoS One (2015) 0.86
Viewing malignant melanoma cells as macrophage-tumor hybrids. Cell Adh Migr (2007) 0.85
Preparation and electrophoretic separation of Bodipy-Fl-labeled glycosphingolipids. J Chromatogr A (2012) 0.85
Expression of peanut agglutinin-binding mucin-type glycoprotein in human esophageal squamous cell carcinoma as a marker. Mol Cancer (2003) 0.85
New insights into germ cell migration and survival/apoptosis in spermatogenesis: Lessons from CD147. Spermatogenesis (2012) 0.85
Monoclonal antibody (5F3) defining renal cell carcinoma-associated antigen disialosyl globopentaosylceramide (V3NeuAcIV6NeuAcGb5), and distribution pattern of the antigen in tumor and normal tissues. Glycoconj J (2001) 0.84